Overview

Study of APD421 With and Without Ondansetron

Status:
Completed
Trial end date:
2018-08-13
Target enrollment:
Participant gender:
Summary
Collection of pharmacokinetic and electrocardiograph data from healthy volunteers given APD421 +/- ondansetron
Phase:
Phase 1
Details
Lead Sponsor:
Acacia Pharma Ltd
Treatments:
Ondansetron